These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15546145)

  • 1. Origins of bidirectional replication of Epstein-Barr virus: models for understanding mammalian origins of DNA synthesis.
    Wang J; Sugden B
    J Cell Biochem; 2005 Feb; 94(2):247-56. PubMed ID: 15546145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes.
    Sears J; Ujihara M; Wong S; Ott C; Middeldorp J; Aiyar A
    J Virol; 2004 Nov; 78(21):11487-505. PubMed ID: 15479791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epstein-Barr Virus Genome Replication as a Molecular Target for Cancer Therapy].
    Noguchi K
    Yakugaku Zasshi; 2019; 139(1):63-67. PubMed ID: 30606931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection.
    Mattia E; Ceridono M; Chichiarelli S; D'Erme M
    Virology; 1999 Sep; 262(1):9-17. PubMed ID: 10489336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
    Tsurumi T
    Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.
    Schepers A; Ritzi M; Bousset K; Kremmer E; Yates JL; Harwood J; Diffley JF; Hammerschmidt W
    EMBO J; 2001 Aug; 20(16):4588-602. PubMed ID: 11500385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.
    Bashaw JM; Yates JL
    J Virol; 2001 Nov; 75(22):10603-11. PubMed ID: 11602702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBNA1 and host factors in Epstein-Barr virus latent DNA replication.
    Frappier L
    Curr Opin Virol; 2012 Dec; 2(6):733-9. PubMed ID: 23031715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1.
    Sugawara Y; Makuuchi M; Kato N; Shimotohno K; Takada K
    EMBO J; 1999 Oct; 18(20):5755-60. PubMed ID: 10523318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
    Yates JL; Camiolo SM; Ali S; Ying A
    Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.
    Skalsky RL; Hu J; Renne R
    J Virol; 2007 Sep; 81(18):9825-37. PubMed ID: 17626102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency.
    Lindner SE; Zeller K; Schepers A; Sugden B
    J Virol; 2008 Jun; 82(12):5693-702. PubMed ID: 18385243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.